Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia
Conditions
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- DRUG: Gemtuzumab Ozogamicin
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
- DRUG: Talazoparib
- DRUG: Talazoparib Tosylate
Sponsor
Roswell Park Cancer Institute
Collaborators